litlas
ログインアカウント作成

Thomas M. Kündig

1991–2025 年に発表

99
論文数
19,598
被引用数
70
h 指数
97
i10 指数

被引用数

Thomas M. Kündig の年別被引用数1991 年: 被引用 6 件1992 年: 被引用 27 件1993 年: 被引用 55 件1994 年: 被引用 130 件1995 年: 被引用 212 件1996 年: 被引用 218 件1997 年: 被引用 278 件1998 年: 被引用 315 件1999 年: 被引用 316 件2000 年: 被引用 332 件2001 年: 被引用 259 件2002 年: 被引用 248 件2003 年: 被引用 186 件2004 年: 被引用 210 件2005 年: 被引用 175 件2006 年: 被引用 163 件2007 年: 被引用 149 件2008 年: 被引用 167 件2009 年: 被引用 148 件2010 年: 被引用 126 件2011 年: 被引用 142 件2012 年: 被引用 154 件2013 年: 被引用 151 件2014 年: 被引用 134 件2015 年: 被引用 133 件2016 年: 被引用 120 件2017 年: 被引用 151 件2018 年: 被引用 136 件2019 年: 被引用 361 件2020 年: 被引用 517 件2021 年: 被引用 406 件2022 年: 被引用 307 件2023 年: 被引用 257 件2024 年: 被引用 372 件2025 年: 被引用 201 件2026 年: 被引用 4 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,949 件、この内訳の 33%ドイツ: 引用元論文 696 件、この内訳の 7.8%イギリス: 引用元論文 556 件、この内訳の 6.2%スイス: 引用元論文 508 件、この内訳の 5.7%中国: 引用元論文 476 件、この内訳の 5.3%カナダ: 引用元論文 379 件、この内訳の 4.2%日本: 引用元論文 358 件、この内訳の 4%フランス: 引用元論文 353 件、この内訳の 4%オーストラリア: 引用元論文 276 件、この内訳の 3.1%イタリア: 引用元論文 247 件、この内訳の 2.8%オランダ: 引用元論文 174 件、この内訳の 2%スペイン: 引用元論文 164 件、この内訳の 1.8%
0%33%その他 20.1%

機関

分野

  • Immunology and Microbiology45.6%
  • Medicine29.2%
  • Biochemistry, Genetics and Molecular Biology16.5%
  • Neuroscience4.1%
  • Pharmacology, Toxicology and Pharmaceutics1%
  • Agricultural and Biological Sciences0.8%
  • その他2.8%

トピック

  • Immune Cell Function and Interaction10.4%
  • T-cell and B-cell Immunology9.9%
  • Immunotherapy and Immune Responses9.3%
  • Immune Response and Inflammation4.6%
  • Allergic Rhinitis and Sensitization1.9%
  • Cytokine Signaling Pathways and Interactions1.8%
  • その他62.1%

共著者

全論文

検索で開く
  1. Inflammation in acute myocardial infarction: the good, the bad and the ugly

    著者: M. Matter, Francesco Paneni, Peter Libby, Stefan Frantz, Barbara E. Stähli, Christian Templin, Alessandro Mengozzi, Yu-Jen Wang, Thomas M. Kündig, Lorenz Räber, Frank Ruschitzka, Christian M. Matter - European Heart Journal 2023 被引用: 312

  2. Stroma-Derived Interleukin-34 Controls the Development and Maintenance of Langerhans Cells and the Maintenance of Microglia

    著者: Melanie Greter, Iva Lelios, Paweł Pelczar, Guillaume Hoeffel, Jeremy Price, Marylène Leboeuf, Thomas M. Kündig, Karl Frei, Florent Ginhoux, Miriam Mérad, Burkhard Becher - Immunity 2012 被引用: 605

  3. The Influence of Antigen Organization on B Cell Responsiveness

    著者: Martin F. Bachmann, Urs Hoffmann Rohrer, Thomas M. Kündig, Kurt Bürki, Hans Hengartner, Rolf M. Zinkernagel - Science 1993 被引用: 733

  4. Protamine-Based Strategies for RNA Transfection

    著者: Natalia Teresa Jarzębska, Mark Mellett, Julia Frei, Thomas M. Kündig, Steve Pascolo - Pharmaceutics 2021 被引用: 91

  5. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients

    著者: Julian H. Birnbaum, Debora Wanner, Anton Gietl, Antje Saake, Thomas M. Kündig, Christoph Höck, Roger M. Nitsch, Christian Tackenberg - Stem Cell Research 2018 被引用: 140

  6. Antigen kinetics determines immune reactivity

    著者: Pål Johansen, Tazio Storni, Lorna Rettig, Zhiyong Qiu, Ani Der-Sarkissian, Kent A. Smith, Vania Manolova, Karl S. Lang, Gabriela Senti, Beat Müllhaupt, Tilman Gerlach, Roberto F. Speck, Adrian Bot, Thomas M. Kündig - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 被引用: 187

  7. Design of in vitro Transcribed mRNA Vectors for Research and Therapy

    著者: Marina Tusup, Lars E. French, Mara De Matos, David Gatfield, Thomas M. Kündig, Steve Pascolo - CHIMIA International Journal for Chemistry 2019 被引用: 54

  8. Virus-induced humoral immunity: on how B cell responses are initiated

    著者: Franziska Zabel, Thomas M. Kündig, Martin F. Bachmann - Current Opinion in Virology 2013 被引用: 112

  9. Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine

    著者: Mona O. Mohsen, Monique Vogel, Carsten Riether, Julius Müller, Silvia Salatino, Nicola Ternette, Ariane C. Gomes, Gustavo Cabral‐Miranda, Aadil El-Turabi, Christiane Ruedl, Thomas M. Kündig, Said Dermime, Alexander Knuth, Daniel E. Speiser, Martin F. Bachmann - Frontiers in Immunology 2019 被引用: 56

  10. Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens

    著者: Federico Storni, Andris Zeltiņš, Ina Baļķe, Matthew D. Heath, Matthias Krämer, Murray Skinner, Lisha Zha, Elisa S. Roesti, Paul Engeroff, Lukas Muri, Diego von Werdt, Thomas Gruber, Mark S. Cragg, Małgorzata Młynarczyk, Thomas M. Kündig, Monique Vogel, Martin F. Bachmann - Journal of Allergy and Clinical Immunology 2019 被引用: 105

  11. Vaccination with nanoparticles combined with micro-adjuvants protects against cancer

    著者: Mona O. Mohsen, Matthew D. Heath, Gustavo Cabral‐Miranda, Cyrill Lipp, Andris Zeltiņš, Marcos Sande-Melón, Jens V. Stein, Carsten Riether, Elisa S. Roesti, Lisha Zha, Paul Engeroff, Aadil El-Turabi, Thomas M. Kündig, Monique Vogel, Murray Skinner, Daniel E. Speiser, Alexander Knuth, Matthias Krämer, Martin F. Bachmann - Journal for ImmunoTherapy of Cancer 2019 被引用: 59

  12. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection

    著者: Klaus Pfeffer, T. Matsuyama, Thomas M. Kündig, Andrew Wakeham, Kenji Kishihara, Arda Shahinian, Katja Wiegmann, Pamela S. Ohashi, Martin Krönke, Tak W. Mak - Cell 1993 被引用: 1,707

  13. IL-12 protects from psoriasiform skin inflammation

    著者: Paulina Kulig, Stephanie Musiol, Sandra N. Freiberger, Bettina Schreiner, Gábor Gyülvészi, Giancarlo Russo, Stanislav Pantelyushin, Kenji Kishihara, Francesca Alessandrini, Thomas M. Kündig, Federica Sallusto, Günther F.L. Hofbauer, Stefan Haak, Burkhard Becher - Nature Communications 2016 被引用: 193

  14. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development

    著者: T. Matsuyama, Tohru Kimura, Motoo Kitagawa, Klaus Pfeffer, Takatoshi Kawakami, Nobumasa Watanabe, Thomas M. Kündig, Ryuichi Amakawa, Kenji Kishihara, Andrew Wakeham, Julia M. Potter, Caren Furlonger, A. Narendran, Haruhiko Suzuki, Pamela S. Ohashi, Christopher J. Paige, Tadatsugu Taniguchi, Tak W. Mak - Cell 1993 被引用: 645

  15. A scalable and highly immunogenic virus‐like particle‐based vaccine against SARS‐CoV‐2

    著者: Mona O. Mohsen, Ina Baļķe, Simon Zinkhan, Villija Zeltina, Xuelan Liu, Xinyue Chang, Pascal S. Krenger, Kevin Plattner, Zahra Gharailoo, Anne‐Cathrine S. Vogt, Gilles Augusto, Marianne Zwicker, Salony Roongta, Dominik A. Rothen, Romano Josi, Joana J. da Costa, Jan M. Sobczak, Aleksandra Nonic, Lee‐Anne Brand, Katja Nuss, B Martina, Daniel E. Speiser, Thomas M. Kündig, Gary T. Jennings, Senta M. Walton, Monique Vogel, Andris Zeltiņš, Martin F. Bachmann - Allergy 2021 被引用: 57

  16. Deregulated T Cell Activation and Autoimmunity in Mice Lacking Interleukin-2 Receptor β

    著者: Haruhiko Suzuki, Thomas M. Kündig, Caren Furlonger, Andrew Wakeham, Emma Timms, T. Matsuyama, Rudolf Schmits, John Simard, Pamela S. Ohashi, Henrik Griesser, Tadatsugu Taniguchi, Christopher J. Paige, Tak W. Mak - Science 1995 被引用: 861

  17. Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function

    著者: Hans‐Willi Mittrücker, T. Matsuyama, Alex Grossman, Thomas M. Kündig, Julia M. Potter, Arda Shahinian, Andrew Wakeham, Bruce Patterson, Pamela S. Ohashi, Tak W. Mak - Science 1997 被引用: 596

  18. Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial

    著者: Gabriela Senti, Bettina M. Prinz Vavricka, Iris Erdmann, Mella I. Diaz, Richárd Márkus, Stephen J. McCormack, John Simard, Brunello Wüthrich, Reto Crameri, Nicole Graf, Pål Johansen, Thomas M. Kündig - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 被引用: 364

  19. PTPN2 Regulates Inflammasome Activation and Controls Onset of Intestinal Inflammation and Colon Cancer

    著者: Marianne R. Spalinger, Roberto Manzini, Larissa Hering, Julianne B. Riggs, Claudia Gottier, Silvia Lang, Kirstin Atrott, Antonia Fettelschoss‐Gabriel, Florian Olomski, Thomas M. Kündig, Michael Fried, Declan F. McCole, Gerhard Rogler, Michael Scharl - Cell Reports 2018 被引用: 100

  20. The next generation virus‐like particle platform for the treatment of peanut allergy

    著者: Jan M. Sobczak, Pascal S. Krenger, Federico Storni, Mona O. Mohsen, Ina Baļķe, Gunta Resēviča, Matthew D. Heath, Thalia L. Carreno Velazquez, Matthias Krämer, Callum J. W. Scott, Murray Skinner, Andris Zeltiņš, Thomas M. Kündig, Monique Vogel, Martin F. Bachmann - Allergy 2023 被引用: 31

  21. Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects

    著者: Franziska Thoms, Gary T. Jennings, Melanie Maudrich, Monique Vogel, Stefanie Haas, Andris Zeltiņš, Regina Hofmann‐Lehmann, Barbara Riond, Jonas Grossmann, Peter Hunziker, Antonia Fettelschoss‐Gabriel, Gabriela Senti, Thomas M. Kündig, Martin F. Bachmann - Journal of Allergy and Clinical Immunology 2019 被引用: 67

  22. CD8 is needed for development of cytotoxic T but not helper T cells

    著者: Wai‐Ping Fung‐Leung, Marco W. Schilham, Amin Rahemtulla, Thomas M. Kündig, Maja Vollenweider, Julia M. Potter, Willem van Ewijk, Tak W. Mak - Cell 1991 被引用: 526

  23. Use of A‐type CpG oligodeoxynucleotides as an adjuvant in allergen‐specific immunotherapy in humans: a phase I/IIa clinical trial

    著者: Gabriela Senti, Pål Johansen, Finn‐Mogens Šmejda Haug, Carroll G. Bull, C. Gottschaller, P Müller, Th. Pfister, Patrik Maurer, Martin F. Bachmann, Norbert Graf, Thomas M. Kündig - Clinical & Experimental Allergy 2009 被引用: 218

  24. Direct intralymphatic injection of peptide vaccines enhances immunogenicity

    著者: Pål Johansen, Andreas C. Häffner, Frauke K. Koch, Karoline Zepter, Iris Erdmann, Kevin J. Maloy, John Simard, Tazio Storni, Gabriela Senti, Adrian Bot, B. Wüthrich, Thomas M. Kündig - European Journal of Immunology 2005 被引用: 125